NYSE: DLBDolby Laboratories Inc Stock
$80.75-1.44 (-1.75%)
Updated Mar 17, 2023
DLB Price
$80.75
Fair Value Price
N/A
Market Cap
$7.74B
52 Week Low
$61.55
52 Week High
$88.06
P/E
42.95x
P/B
3.38x
P/S
5.47x
PEG
1.15x
Dividend Yield
1.29%
Revenue
$1.24B
Earnings
$183.45M
Gross Margin
88.4%
Operating Margin
18.13%
Profit Margin
14.8%
Debt to Equity
0.2
Operating Cash Flow
$343M
Beta
0.95
Next Earnings
May 3, 2023
Ex-Dividend
N/A
Next Dividend
N/A
DLB Overview
Dolby Laboratories, Inc. offers audio and surround sound for cinema, broadcast, home audio systems, in-car entertainment systems, DVD players, games, televisions, and personal computers. The company generates most of its revenue from licensing its technology to consumer electronics manufacturers around the world. Dolby Labs was founded in 1965 and is headquartered in San Francisco, CA.
Zen Score
–
Industry Average (25)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how DLB scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
DLB ($80.75) is trading above its intrinsic value of $35.20, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
DLB is poor value based on its earnings relative to its share price (42.95x), compared to the US market average (21.81x)
P/E vs Market Valuation
DLB is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more DLB due diligence checks available for Premium users.
Be the first to know about important DLB news, forecast changes, insider trades & much more!
DLB News
Valuation
DLB price to earnings (PE)
For valuing profitable companies with steady earnings
Company
42.95x
Industry
31.37x
Market
21.81x
DLB is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
DLB is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
DLB price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
3.38x
Industry
1.99x
DLB is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
DLB price to earnings growth (PEG)
For valuing profitable companies with growth potential
DLB is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
DLB's financial health
Profit margin
Revenue
$334.9M
Net Income
$79.4M
Profit Margin
23.7%
DLB's Earnings (EBIT) of $224.32M... subscribe to Premium to read more.
Interest Coverage Financials
DLB's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$2.7B
Liabilities
$456.0M
Debt to equity
0.2
DLB's short-term assets ($1.35B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
DLB's short-term assets ($1.35B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
DLB's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
DLB's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$56.4M
Investing
$28.3M
Financing
-$90.1M
DLB's operating cash flow ($343.31M)... subscribe to Premium to read more.
Debt Coverage Financials
DLB vs Entertainment Stocks
Dolby Laboratories Stock FAQ
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.